Harpoon
is a California-based biotechnology company that researches and develops T-cell immunotherapies for the treatment of cancer and infectious diseases... Read moreHarpoon
is a California-based biotechnology company that researches and develops T-cell immunotherapies for the treatment of cancer and infectious diseases... Read more
CEO
- -News
Jun 03, 2024
MarketScreener
Harpoon: Harpoon Therapeutics : June 3, 2024
Apr 03, 2024
MarketScreener
Harpoon: Harpoon Therapeutics : April 3, 2024
Mar 13, 2024
Pharmabiz
Harpoon: Merck completes acquisition of Harpoon Therapeutics
Mar 12, 2024
Pharamceutical Technology
Harpoon: Merck completes Harpoon Therapeutics acquisition
Mar 11, 2024
Business Wire
Harpoon: Merck Completes Acquisition of Harpoon Therapeutics, Inc.
Feb 06, 2024
PR-Inside
Press Release: Harpoon : STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating ...
Jan 23, 2024
Global Legal Chronicle
Harpoon: Merck's $680 Million Acquisition of Harpoon Therapeutics
Jan 19, 2024
MarketScreener
Harpoon: Arix Bioscience eyes USD19 million return from Harpoon sale
Jan 11, 2024
Americanbankingnews
Harpoon: Harpoon Therapeutics, Inc. (NASDAQ:HARP) to Post FY2025 Earnings of ($2.09) Per Share, Leerink Partnrs Forecasts
Jan 11, 2024
PMLiVE
Harpoon: Merck expands cancer immunotherapy pipeline with $680m Harpoon acquisition
Harpoon Competitors
1
2
3
4
5
6
7
8
9
10